surmount 3 tirzepatide SURMOUNT-5: shows superior weight loss over semaglutide Tirzepatide Further Cements Weight Loss

Oral semaglutide offers superior blood glucose lowering versus multiple comparators 9,10 , together with consistent weight reduction 9,10,11 , reduction in cardiometabolic risk factors 11 and reduction in major adverse cardiovascular events (MACE)

GLP-1 receptor agonists and metabolic effects

OS has also been implicated in the process of ovarian ageing and an increased incidence of aneuploidy in ageing oocytes

The injection itself follows standard subcutaneous technique

The typical dose is 35 grams daily, which does not interfere with semaglutide's mechanism of action

That said, this guide isn't intended to be taken as definitive